Glaxosmithkline Consumer Healthcare

GSK to sell Horlicks to fund $13 bn Novartis deal; Nestle, Kraft, Unilever likely suitors, say sources

GSK has started a strategic review of Horlicks - a malt-based drink brand popular in India – and some of its smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion on Tuesday.

Horlicks Nutribic invites consumers to unveil new TVC

Launches consumer engagement on Facebook